The Optimal Killer Cell Immunoglobulin-Like Receptor Donor—We Can Recognize, but Can We Search?
Open Access
- 1 January 2019
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 25 (1) , e3-e4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- KIR Donor Selection: Feasibility in Identifying better DonorsTransplantation and Cellular Therapy, 2019
- Can we make a better match or mismatch with KIR genotyping?Hematology-American Society Hematology Education Program, 2016
- Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous LeukemiaThe Journal of Immunology, 2014
- Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolutionNature Reviews Immunology, 2013
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemiaBlood, 2010
- Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemiaBlood, 2009
- Participation in Cancer Clinical TrialsJAMA, 2004
- Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to EnrollmentJournal of Clinical Oncology, 2001
- In search of the ‘missing self’: MHC molecules and NK cell recognitionImmunology Today, 1990
- Cooperative groups and community hospitals. Measurement of impact in the community hospitalsCancer, 1983